Precision Optics Corporation Inc (POCI) FinancialsPOCIFinancialPrecision Optics Corporation Inc

Precision Optics Corporation Inc (POCI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Systems Manufacturing, accounting for 72.8% of total sales, equivalent to $4.87M. Other significant revenue streams include Ross Optical Industries and Engineering Design Services. Understanding this composition is critical for investors evaluating how POCI navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Precision Optics Corporation Inc maintains a gross margin of 23.61%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -0.74%, while the net margin is -1.24%. These profitability ratios, combined with a Return on Equity (ROE) of -29.62%, provide a clear picture of how effectively POCI converts its operational activities into shareholder value.

In the context of the broader market, POCI competes directly with industry leaders such as BDMD and NEPH. With a market capitalization of $47.99M, it holds a significant position in the sector. When comparing efficiency, POCI's gross margin of 23.61% stands against BDMD's 83.79% and NEPH's 66.43%. Such benchmarking helps identify whether Precision Optics Corporation Inc is trading at a premium or discount relative to its financial performance.

POCI has shown significant revenue growth, with Q3 2026 revenue at $8.7 million, up from $4.2 million in Q3 2025. The gross margin has improved to 23.61% in Q3 2026, a notable recovery from previous quarters.